401, Novartis iNvestiagtional Site — Atlanta, Georgia

401, Novartis iNvestiagtional Site is a clinical research site located in Atlanta, Georgia, United States 30322.

Crixeo Health Trust Score: 51/100 (POOR). This profile has not yet been claimed by the site owner.

401, Novartis iNvestiagtional Site has participated in 1 clinical trials.

Therapeutic areas: Influenza Virus.

Sponsors: Seqirus.

Sponsor Feasibility Report

Trust Score: 51/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for 401, Novartis iNvestiagtional Site?

401, Novartis iNvestiagtional Site has a Crixeo Trust Score of 51/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has 401, Novartis iNvestiagtional Site conducted?

401, Novartis iNvestiagtional Site has 1 clinical trials on record. Their work covers Influenza Virus.

Is 401, Novartis iNvestiagtional Site accredited by Crixeo Health?

401, Novartis iNvestiagtional Site has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about 401, Novartis iNvestiagtional Site?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.